title: Drawing the Line in Risk-Reducing Gynecologic Surgery in Women With a BRCA Mutation.
authors.affiliation: Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham.
authors.forename: Charles A
authors.initials: CA
authors.lastname: Leath
authors.affiliation: Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham.
authors.forename: Warner K
authors.initials: WK
authors.lastname: Huh
authors.affiliation: Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham.
authors.forename: Ronald D
authors.initials: RD
authors.lastname: Alvarez
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000139:chemically induced / Q000235:genetics / Q000517:prevention & control; D003131:Combined Modality Therapy; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D013509:Gynecologic Surgical Procedures; D006801:Humans; D019060:Minimally Invasive Surgical Procedures; D009154:Mutation; D059351:Organ Sparing Treatments; D012306:Risk; D040242:Risk Reduction Behavior; D014594:Uterine Neoplasms / Q000235:genetics / Q000601:surgery*
chemical_list: D018931:Antineoplastic Agents, Hormonal